Screening for domestic and sexualized violence in the emergency department

Screening for domestic and sexualized violence in the emergency department - SHuSG-NA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00035155

Enrollment

2500

Registered

2024-10-01

Start date

2024-10-01

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

domestic and sexualized violence

Interventions

Group 1: All patients who present to the participating emergency departments 24/7 will be approached regarding participation in the screening. If desired, patients will complete a short tablet-based a

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All adult patients aged =18 years who are cognitively able to complete the screening and agree to participate

Exclusion criteria

Exclusion criteria: Insufficient opportunity for screening (language barrier, cognition, urgent need for care, no protected setting)

Design outcomes

Primary

Measure	Time frame
Prevalence of self-reported experience of domestic and sexualized violence in the last 12 months in the three participating emergency departments of Charité - Universitätsmedizin Berlin as a proportion of positively screened patients out of all patients in the survey period (one month each location).	—

Secondary

Measure	Time frame
1) Demographic and clinical characterization of positively screened DaSV patients (DaSV - domestic and sexualized volence) anonymous interview (age, gender, how the patient came to the emergency department, grouped admission time, day of the week), comparison with other patients in the emergency department. 2) Demographic and clinical characterization of positively screened DaSV patients for consented patients (age, gender, nationality, date of admission, time of admission, transport bringing in, triage, reason for treatment, type of case, stay from the emergency department, further inpatient treatment - admitting and discharging specialty, main hospital diagnosis, admission and discharge date and time), comparison with other patients in the emergency department. 3) Subgroups with particularly high DaSV prevalence based on socio-demographic and presentation characteristics. 4) Relative frequency of positively screened patients with the primary reason for treatment being DaSV out of all positively screened patients (consented patients). 5) Relative frequency of positively screened patients without DaSV as the primary reason for treatment and documented treatment occasions of these subgroups among all positively screened patients (consented patients). 6) Relative frequency of desired counseling on support services for positively screened patients out of all positively screened patients. 7) Inhibiting and promoting factors for the implementation of screening for DaSV in the emergency department.	—

Measure

Time frame

1) Demographic and clinical characterization of positively screened DaSV patients (DaSV - domestic and sexualized volence) anonymous interview (age, gender, how the patient came to the emergency department, grouped admission time, day of the week), comparison with other patients in the emergency department. 2) Demographic and clinical characterization of positively screened DaSV patients for consented patients (age, gender, nationality, date of admission, time of admission, transport bringing in, triage, reason for treatment, type of case, stay from the emergency department, further inpatient treatment - admitting and discharging specialty, main hospital diagnosis, admission and discharge date and time), comparison with other patients in the emergency department. 3) Subgroups with particularly high DaSV prevalence based on socio-demographic and presentation characteristics. 4) Relative frequency of positively screened patients with the primary reason for treatment being DaSV out of all positively screened patients (consented patients). 5) Relative frequency of positively screened patients without DaSV as the primary reason for treatment and documented treatment occasions of these subgroups among all positively screened patients (consented patients). 6) Relative frequency of desired counseling on support services for positively screened patients out of all positively screened patients. 7) Inhibiting and promoting factors for the implementation of screening for DaSV in the emergency department.

—

Countries

Germany

Contacts

Public ContactAnna Slagman

Charité - Universitätsmedizin Berlin

anna.slagman@charite.de+4930 450 565 659

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026